Featured News

Does living with celiac disease impact your daily life? We need your help to advance celiac disease research and test an investigational medication.  

The Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.

There are more exciting opportunities than ever before to participate in celiac disease clinical trials. Researchers are making groundbreaking progress in the race for better treatments with promising new drug candidates.

Thank you to Provention Bio, Inc., for supporting our upcoming Patient Education and Advocacy Summit. Provention Bio, Inc., is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. Register now to be a part of this monumental event!

Dietitians and doctors say a new federal bill to extend Medicare coverage for nutritional therapy provided by a registered dietitian would provide better healthcare for Americans with celiac disease.